Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
09/2005
09/21/2005EP1294679B1 Beta-amino acid nitrile derivatives
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/21/2005CN1671696A 激酶抑制剂 Kinase inhibitors
09/20/2005US6946478 Compounds
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/15/2005US20050203273 Novel one-dimensional coordination polymer
09/15/2005US20050203149 Alkanamide alpha-monohydrazone derivatives, e.g., N-(4-chlorobenzyl)-2-(4-trifluoromethylphenylhydrazono)propionamide, for agricultural and horticultural use, clothing, food and housing-related use, or livestock and pet use
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050202973 Aryl-alkyne compounds as herbicides
09/15/2005US20050198748 Water-soluble fiber-reactive dyes, method for the production and use thereof
09/15/2005CA2558109A1 Heteroaryl-fused pyrazolo derivatives
09/14/2005EP1574542A1 Novel one-dimensional coordination polymer
09/14/2005EP1572670A1 5-substituted-pyrazine or -pyridine glucokinase activators
09/14/2005EP1572669A2 2,5-diketopiperazines for the treatment of obesity
09/14/2005EP1572630A1 Antibacterial agents
09/14/2005EP1572209A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists
09/14/2005EP1409440A4 A method to inhibit ethylene responses in plants
09/14/2005EP1091737B1 Use of 1-(3,3-diphenylpropionyl)-4-benzhydril piperazine in the treatment of pain
09/14/2005CN1669162A Electrode-active material and electrodes made by using the same, and cells equipped with the electrodes
09/14/2005CN1668703A Charge transport compositions on the basis of triarylmethanes and their use in electronic devices
09/14/2005CN1668616A Charge transport compositions comprising fluorizated quinazoline derivatives
09/14/2005CN1668604A Novel anthracene derivatives and the use thereof as a medicament
09/14/2005CN1218944C Chemosynthesis method of 1-chloroformyl-4-ethyl-2, 3-dioxopiperazine
09/13/2005US6943179 Biurethane derivatives
09/13/2005US6943170 N-cycloalkylglycines as HIV protease inhibitors
09/10/2005CA2500101A1 Novel one-dimensional coordination polymer
09/09/2005WO2005082425A1 Catalytic radiofluorination
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005CA2825161A1 Catalytic radiofluorination
09/09/2005CA2552356A1 Catalytic radiofluorination
09/07/2005EP1569917A1 Pyrazine-based tubulin inhibitors
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005CN1666577A Electronic devices made with electron transport and/or anti-quenching layers
09/07/2005CN1666357A Polymeric charge transport compositions and electronic devices made with such compositions
09/07/2005CN1665809A Azaindoles
09/07/2005CN1665792A Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1217932C Antibacterial agents
09/06/2005US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine,
09/06/2005US6939885 Sulfur compounds such as 4-tert-Butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide, used as chemokine receptor antagonists, antiinflamatory agents or as immunology modulators
09/01/2005WO2005080506A1 Novel modified crystal of 3,6-bis(dimethylamino)-2,5-pyrazinedicarbonitrile
09/01/2005WO2005080361A1 Histamine-3 receptor modulators
09/01/2005WO2005080360A1 Compounds
09/01/2005WO2005079799A1 4-acyl-piperazines as anti-viral agents
09/01/2005WO2005079574A1 Bicyclic melanocorin-specific compounds
09/01/2005CA2555071A1 Histamine-3 receptor modulators
09/01/2005CA2554686A1 Compounds
08/2005
08/31/2005EP1568367A1 Compounds effecting glucokinase
08/31/2005EP1567486A2 Bis-aryl sulfonamides
08/31/2005EP1003497B1 Il-8 receptor antagonists
08/31/2005CN1662499A Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
08/31/2005CN1662487A Amide linker peroxisome proliferator activated receptor modulators
08/31/2005CN1662484A Process for preparing (r)-aryloxypropionic acid ester derivatives
08/31/2005CN1662236A Inhibitors of histone deacetylase
08/31/2005CN1660821A Oxodiethylenediamine derivative and light stabilized composition
08/31/2005CN1660811A Compound of 1, 4-substituted benzenes and preparing method and application
08/31/2005CN1216947C Reactive dye compounds
08/30/2005US6936610 Heterocyclic derivatives
08/30/2005US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
08/25/2005WO2005077920A1 Quinoxaline compounds and methods of using them
08/25/2005WO2005077919A1 Novel cyanopyrazine derivative
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005US20050187272 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation
08/25/2005US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine
08/25/2005US20050186446 Phosphorescence; personal computer, portable telephone, television receiver
08/25/2005US20050186176 Compounds and compositions for delivering active agents
08/25/2005CA2555291A1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
08/24/2005EP1565454A1 Pyrazine compounds as crf modulators
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659156A Novel guanidinobenzamides
08/24/2005CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
08/24/2005CN1658724A Luminescent element material and luminescent element comprising the same
08/24/2005CN1216018C Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
08/23/2005US6933412 Low loss high refractive index vinyl sulfide compounds and method of making same
08/18/2005WO2005075438A1 Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases
08/18/2005WO2005030794A3 Hemiasterlin derivatives and uses thereof
08/18/2005WO2005021547A3 Heterocyclic cannabinoid cb2 receptor antagonists
08/18/2005US20050182256 1-{1-[4-(6-hydroxy-5-isobutyl-3-phenylpyrazin-2-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; antiproliferative
08/18/2005US20050182096 Haloalkyl containing compounds as cysteine protease inhibitors
08/18/2005US20050182054 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
08/18/2005US20050182047 Treatment of demyelinating disorders
08/18/2005CA2554705A1 Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases
08/17/2005EP1562940A2 Aryl sulfonamides
08/17/2005EP1562902A1 2-pyridone derivatives as inhibitors of neutrophile elastase
08/17/2005EP1562595A1 Diaryl ethers as opioid receptor antagonists
08/17/2005EP1562574A1 2-oxo-ethanesulfonamide derivates
08/17/2005EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
08/17/2005EP1144385B1 Benzoheterocycles and their use as mek inhibitors
08/17/2005CN1656099A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
08/17/2005CN1656082A Protein kinase inhibitors
08/17/2005CN1656072A Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
08/17/2005CN1655818A Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
08/16/2005US6930112 Administering antagonist for n-methylaspartic acid or gamma-aminobutyric acid
08/16/2005US6930106 Inhibitors of HCV NS5B polymerase
08/11/2005WO2005073165A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
08/11/2005WO2005072733A1 Dyarylurea compounds as chk-1 inhibitors
08/11/2005WO2005072361A2 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005WO2004110983A8 New benzamides as pparϒ modulators
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 187